News
Jefferies Initiates Coverage On PMV Pharma with Buy Rating, Announces Price Target of $5
12 Apr 24
News, Price Target, Initiation, Analyst Ratings
PMV Pharmaceuticals PYNNACLE Phase I Data Of Rezatapopt In Advanced Ovarian Cancer Featured In Oral Presentation At 2024 SGO Annual Meeting On Women's Cancer
18 Mar 24
Biotech, News, General
HC Wainwright & Co. Reiterates Buy on PMV Pharma, Maintains $5 Price Target
7 Mar 24
News, Price Target, Reiteration, Analyst Ratings
Press releases
PMV Pharmaceuticals Announces First Patient Dosed in Global Tumor-Agnostic Phase 2 PYNNACLE Trial for Rezatapopt in TP53 Y220C-Positive Solid Tumors
27 Mar 24
Health Care, Press Releases
PMV Pharmaceuticals PYNNACLE Phase I Data of Rezatapopt in Advanced Ovarian Cancer Featured in Late-Breaking Oral Presentation at 2024 SGO Annual Meeting on Women's Cancer
18 Mar 24
Health Care, Press Releases
PMV Pharmaceuticals Reports Full Year 2023 Financial Results and Corporate Highlights
29 Feb 24
Earnings, Press Releases